Autologous Chondrocyte Implantation in the Patellofemoral Joint

Completed

Conditions studied: Chondrosis, Patellar Articular Cartilage Lesions, Trochlear Articular Cartilage Lesions

In brief

The purpose of this study is to measure the outcomes of patients who have articular cartilage lesions in the patellofemoral joint and are treated with the Autologous Chondrocyte Implantation.

Key facts

Study ID

NCT00212849

Run by

Orthopaedic Research Foundation

People needed

35

Starts

1995-01-01

Expected to finish

2005-08-01

Last updated by the study team

2005-09-21

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Carticel Implantation of the patella and/or trochlear lesion. Patients who have reached their two-year follow-up date. All patients included in sequential order.

You may not qualify if…

• Patients that have had a microfracture in the knee joint at the same time as Carticel Implantation.
• Patients that have implantable lesions other than the patella and trochlea.

Where it is running

• Orthopaedics Indianapolis — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.